Degradation of cyclophosphamide and 5-fluorouracil by UV and simulated sunlight treatments: Assessment of the enhancement of the biodegradability and toxicity
-
Add time:07/18/2019 Source:sciencedirect.com
The presence of pharmaceuticals in the environment has triggered concern among the general population and received considerable attention from the scientific community in recent years. However, only a few publications have focused on anticancer drugs, a class of pharmaceuticals that can exhibit cytotoxic, genotoxic, mutagenic, carcinogenic and teratogenic effects. The present study investigated the photodegradation, biodegradation, bacterial toxicity, mutagenicity and genotoxicity of cyclophosphamide (CP) and 5-fluorouracil (5-FU). The photodegradation experiments were performed at a neutral to slight pH range (7–7.8) using two different lamps (medium-pressure mercury lamp and a xenon lamp). The primary elimination of the parent compounds was monitored by means of liquid chromatography tandem mass spectrometry (LC-IT-MS/MS). NPOC (non-purgeable organic carbon) analyses were carried out in order to assess mineralization rates. The Closed Bottle Test (CBT) was used to assess ready biodegradability. A new method using Vibrio fischeri was adopted to evaluate toxicity. CP was not degraded by any lamp, whereas 5-FU was completely eliminated by irradiation with the mercury lamp but only partially by the Xe lamp. No mineralization was observed for the experiments performed with the Xe lamp, and a NPOC removal of only 18% was registered for 5-FU after 256 min using the UV lamp. Not one of the parent compounds was readily biodegradable in the CBT. Photo transformation products (PTPs) resulting from photolysis were neither better biodegradable nor less toxic than the parent compound 5-FU. In contrast, the results of the tests carried out with the UV lamp indicated that more biodegradable and non-toxic PTPs of 5-FU were generated. Three PTPs were formed during the photodegradation experiments and were identified. The results of the in silico QSAR predictions showed positive mutagenic and genotoxic alerts for 5-FU, whereas only one of the formed PTPs presented positive alerts for the genotoxicity endpoint.
We also recommend Trading Suppliers and Manufacturers of CyclophosphaMide IMpurity D (cas 45164-26-9). Pls Click Website Link as below: cas 45164-26-9 suppliers
Prev:Competitive binding of anticancer drugs 5-fluorouracil and cyclophosphamide with serum albumin: Calorimetric insights
Next:Guidelines and pharmacopoeial standards for pharmaceutical impurities: Overview and critical assessment) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug product07/22/2019
- Correlation of liquid chromatographic and biological assay for potency assessment of filgrastim and related impurities07/20/2019
- Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography–mass spectrometry07/21/2019
- Guidelines and pharmacopoeial standards for pharmaceutical impurities: Overview and critical assessment07/19/2019
- Competitive binding of anticancer drugs 5-fluorouracil and cyclophosphamide with serum albumin: Calorimetric insights07/17/2019
- Determination of the impurities in drug products containing montelukast and in silico/in vitro genotoxicological assessments of sulfoxide impurity07/16/2019
- Cyclophosphamide enhances the release of tumor exosomes that elicit a specific immune response in vivo in a murine T-cell lymphoma07/15/2019
- Crystallization of Cyclophosphamide Monohydrate During Lyophilization07/14/2019


